Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1

Interventions

Cytarabine 5Cyclophosphamide 4Clofarabine 4Vorinostat 3Sorafenib 3Arsenic Trioxide 3fludarabine phosphate 2Topotecan 2Lenalidomide 2Idarubicin 2Filgrastim 2Etoposide 2vadastuximab talirine 1tipifarnib 1tamibarotene 1romidepsin 1perifosine 1octadecyl-(N,N-dimethylpiperidino-4-yl)-phosphate 1ispinesib 1entinostat 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1belinostat 1Thiotepa 1Radiotherapy 1Methoxsalen 1Magnetic Resonance Spectroscopy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Gadolinium 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Promyelocytic, Acute × tamibarotene × Clear all
NCT00985530 2013-10-30

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

Northwestern University

Phase 1 Terminated
4 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡